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Severe sepsis, may be present on hospital arrival in approximately one-third of patients with
community-acquired pneumonia (CAP).
Objective
To determine the host characteristics and micro-organisms associated with severe sepsis
in patients hospitalized with CAP.
Results
We performed a prospective multicenter cohort study in 13 Spanish hospital, on 4070 hospi-
talized CAP patients, 1529 of whom (37.6%) presented with severe sepsis. Severe sepsis
CAP was independently associated with older age (>65 years), alcohol abuse (OR, 1.31;
95% CI, 1.07–1.61), chronic obstructive pulmonary disease (COPD) (OR, 1.75; 95% CI,
1.50–2.04) and renal disease (OR, 1.57; 95% CI, 1.21–2.03), whereas prior antibiotic treat-
ment was a protective factor (OR, 0.62; 95% CI, 0.52–0.73). Bacteremia (OR, 1.37; 95% CI,
1.05–1.79), S pneumoniae (OR, 1.59; 95% CI, 1.31–1.95) and mixed microbial etiology
(OR, 1.65; 95% CI, 1.10–2.49) were associated with severe sepsis CAP.
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Conclusions
CAP patients with COPD, renal disease and alcohol abuse, as well as those with CAP due
to S pneumonia or mixed micro-organisms are more likely to present to the hospital with
severe sepsis.
Introduction
With an incidence of 3–5 cases per 1000 adults/year, Community-acquired pneumonia (CAP),
is a frequent cause of death worldwide [1–3]. A complication of CAP is severe sepsis, the syn-
drome of infection complicated by systemic inflammation and organ dysfunction. Severe sepsis
is a worldwide health problem, with an incidence of 343 cases per 100,000 habitants in the
USA. At least one-third of CAP patients present to the hospital with severe sepsis.[4,5]
Initial identification of the severity of sepsis is important in order to institute different man-
agement and monitoring measures.[6] Clinicians often do not recognize the presence of severe
sepsis in CAP patients, even when organ dysfunction is present. Studies aimed at identifying
the CAP population at risk of developing severe sepsis in the community before arriving at hos-
pital are lacking.
The aim of our study was to determine the risk factors for presentation at the hospital with
severe sepsis in patients with CAP.
Materials and Methods
Patients and Data Collection
A prospective, multi-center, observational cohort study was carried out in 13 hospitals belonging
to the Spanish national health system (CAP Quality Group); a complete, detailed description has
been reported in a prior publication.[7] Briefly, the inclusion criterion was a diagnosis of CAP,
defined as acute symptoms or signs with a new compatible radiographic lung infiltrate. Exclusion
criteria were nursing-home patients, transplant or oncologic patients, leukopenia or neutropenia
(unless attributable to pneumonia), Human Immunodeficiency Virus-positive (HIV) patients
with severe immunosuppression (CD4<100), treatment with corticosteroids (>20 mg/day) or
other immunosuppressive drugs, and patients with DNR (do not resuscitate) orders or in whom
CAP was considered a terminal event. The study was approved by the ethics committee (ISS Hos-
pital La Fe 2004/15 July, Assent 2004/0101) and the patients provided written informed consent.
We recorded data on age, gender, prior antibiotic treatment for the current episode, comor-
bid conditions (chronic obstructive pulmonary disease [COPD], heart, liver, neurological or
renal diseases, and diabetes mellitus), clinical, analytical and radiological results, and the prog-
nostic scales Pneumonia Severity Index (PSI) [8] and CURB65 risk class. [9]
Definitions
Comorbidities were assessed based on clinical history along with prior discharge diagnoses and
clinical records, review of medications and results of analyses. [8] Sepsis and severe sepsis were
evaluated at CAP diagnosis on hospital admission, following previously accepted criteria.
[4,7,10] Sepsis was defined as the presence of pneumonia and systemic inflammatory response
syndrome (SIRS). Severe sepsis was considered if criteria for sepsis were met and acute failure
of at least one organ was present: arterial hypoxemia (PaO2/FiO2<300), creatinine>2 mg/dL,
acute confusion or hypotension (systolic arterial tension [ST]<90 mmHg). While organ dys-
function has also been defined in terms of hepatic or hematologic failure, information on these
organ systems were not available in the data set.
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Microbiological Analysis and Diagnostic criteria
Microbiological studies comprised the following: 2550 (62.7%) blood cultures, 3636 (89.3%)
urinary antigens for Legionella pneumophila and 3654 (89.8%) for Streptococcus pneumonia,
1760 (43.2%) sputum cultures, 1902 (46.7%) paired serological studies for Chlamydophila
pneumoniae,Mycoplasma pneumoniae, Coxiella burnetii and Legionella pneumophila, naso-
pharyngeal swabs to detect viral nucleic acids, invasive samples obtained by bronchoscopy
(285 [7%] bronchial aspirate [BAS] and 118 [2.9%] bronchoalveolar lavage [BAL]), and 276
(6.8%) pleural fluid cultures.
Microbiologic diagnostic criteria were the following: 1) positive urinary antigens for S pneu-
moniae and Legionella pneumophila; 2) isolation of microorganisms in BAL (104 UFC/mL),
BAS (105 UFC/mL) or in pleural fluid; 3) isolation of one predominant microorganism in
sputum or L pneumophila in buffered charcoal yeast extract (BCYE) agar; 4) microorganisms
in blood culture; 5) seroconversion or a fourfold antibody increase in titers of IgG for C pneu-
moniae ( 1:512),M pneumoniae and C burnetii, ( 1:160) or IgM 1:32 for C pneumoniae,
and 1:80 forM pneumoniae and C burnetii; 5) positive detection of viral nucleic acids in
nasopharyngeal swab.
Mixed etiology was defined as pneumonia due to more than one pathogen (virus or bacte-
ria). [11]
Outcome Measurements
The evaluated outcome was mortality during hospitalization and at 30-day and 90-day follow-
up. Length of stay (LOS) was defined as the number of days from hospital admission to
discharge.
Statistical Study
Data analysis was performed using the SPSS statistical software package, version 15.0. Categor-
ical variable results were expressed as count (percentage) and were compared using the χ2 test.
Continuous variables were expressed as median with interquartile range (IQR) and were ana-
lyzed using non-parametric tests. PSI and CURB65 scales were categorized as low risk (PSI
III/ CURB652) and high risk (PSI>III/ CURB653). Severe sepsis was dichotomized as
yes (severe sepsis criteria at hospital admission) and no (non-severe sepsis criteria, the refer-
ence group).
Two multivariable statistical studies to predict risk factors for severe-sepsis CAP, the depen-
dent variable, were performed using stepwise logistic regression analyses. In the first model,
the included independent variables were those related to characteristics of patients. In the sec-
ond model, the independent variables were those related to etiology (causal microorganisms).
In both models, the independent variables were those found to be significant in the univariate
analyses. The Hosmer and Lemeshow goodness-of-fit test was performed to evaluate the ade-
quacy of the models. [12]
Results
Study Population
The cohort comprised 4374 patients presenting to the emergency department with CAP and
admitted to hospital. We studied 4070 patients after excluding 237 nursing-home and 66 DNR
patients: 1529 (37.6%) had severe-sepsis (Table 1).
Mortality for the whole cohort was 3.3% and the median length of stay was 7 (IQR 4–10)
days. Mortality was significantly higher in severe sepsis CAP (Table 2).
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Patient Characteristics
Characteristics related to severe sepsis CAP compared to the reference group are shown in
Table 1. Severe-sepsis CAP was more frequent in men, patients older than 65 years, and those
with COPD and renal disease, whereas diabetes mellitus was more frequent in those without sep-
sis. Severe-sepsis CAP also presented with higher PSI and CURB65 scores and more multilobar
infiltrates. Patients who received prior antibiotic treatment had lower rates of severe-sepsis.
Table 1. Characteristics of CAP with severe sepsis: demographic data, comorbid conditions, radiographic and prognostic scales data.
Characteristics Severe Sepsis
No, n (%) Yes, n (%) pc
Total No. n = 2,541 n = 1,529
Demographic data Age* 69 (50–78) 73 (60–81) <0.001
Age 65 years 1473 (58.1) 1024 (67.1) <0.001
Male gender 1635 (64.3) 1065 (69.7) 0.001
Current smoker 574 (22.6) 343 (22.5) 0.937
Alcohol abusea 273 (10.7) 200 (13.1) 0.024
Prior corticosteroid treatmentb 95 (3.8) 74 (4.9) 0.083
Prior antibiotic treatment 651 (25.6) 261 (17.1) <0.001
Comorbid condition Diabetes Mellitus 566 (22.3) 294 (19.2) 0.020
Liver disease 102 (4) 70 (4.6) 0.378
Heart disease 346 (13.6) 227 (14.8) 0.277
Renal disease 136 (5.4) 132 (8.6) <0.001
Neurological disorders 245 (9.7) 157 (10.3) 0.531
COPD 494 (19.8) 477 (32.0) <0.001
Radiographic ﬁndings Multilobar inﬁltrates 501 (19.7) 427 (27.9) <0.001
Pleural Effusion 391 (15.4) 248 (16.3) 0.469
Prognostic scales PSI (IV-V) 866 (34.1) 971 (63.5) <0.001
CURB65 ( 3) 531 (20.9) 663 (43.3) <0.001
Data are presented as number (percentage) unless otherwise indicated.
*Data are presented as median (interquartile range).
a Alcohol abuse: more than 80 g/day.
b Previous corticosteroid treatment: less than 20 mg/day prednisone or equivalent.
c p value: the χ2 test was performed for categorical data and the Mann-Whitney U test was performed for continuous data.
doi:10.1371/journal.pone.0145929.t001
Table 2. Length of stay andmortality in CAP with regard to severe sepsis.
Severe Sepsis
No, n (%) Yes, n (%) p valueb ORc 95% CId
Total No. n = 2,541 n = 1,529
LOSa 6 (4–9) 8 (5–12) <0.001
Mortality At 30 days 75 (3) 104 (6.9) <0.001 2.404 1.773–3.258
At 90 days 102 (4.2) 127 (8.8) <0.001 2.194 1.676–2.872
Data are presented as number (percentage) unless otherwise indicated.
a LOS: Length of stay (days). Data are presented as median (interquartile range).
b p value: the χ2 test was performed for categorical data and the Mann-Whitney U test was performed for continuous data.
c OR: Odds ratio.
d CI: Conﬁdence interval.
doi:10.1371/journal.pone.0145929.t002
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Etiology
Etiological diagnosis in the whole cohort was reached in 1506 (37%) patients: 859 (57%)
S pneumoniae, 104 (6.9%) L pneumophila, 44 (2.9%) C pneumoniae, 50 (3.3%) C burnetii,
50 (3.3%)M pneumoniae, 45 (3%) Pseudomonas aeruginosa, 43 (2.9%) Haemophilus influen-
zae, 18 (1.2%) viruses, 15 (1%) E coli and 121 (8%) mixed etiology.
Severe-sepsis CAP patients had the highest percentage of identified causal microorganisms
and more bacteremic episodes. S pneumoniae was the most frequent microorganism found,
with a higher percentage in severe sepsis. Atypical microorganisms were more frequent in
patients with non-severe sepsis, whereas mixed etiology appeared more often in severe-sepsis
CAP. Mixed etiology was caused mainly by S pneumoniae (29.3% with virus or atypical patho-
gens, 13.8% with Pseudomonas aeruginosa and 5.1% with S aureus) (Table 3).
Multivariable Statistical Analyses
Four independent risk factors related to patients’ characteristics were associated with severe-
sepsis CAP: age>65 years, alcohol abuse, renal disease and COPD, whereas prior antibiotic
treatment and diabetes were protective factors. With regard to causal microorganisms, S pneu-
moniae, mixed etiology and bacteremia were found to be risk factors (Table 4).
Discussion
The most important findings of our study were: 1) 37.6% of hospitalized CAP patients had
developed community-onset severe sepsis already at admission; 2) elderly patients, alcohol
abusers, patients with renal disease and COPD patients were more likely to develop
Table 3. Etiology of CAP in relation to severe sepsis.
Etiology Severe Sepsis
Groups No, n (%) Yes, n (%) pa
Total No. Total No. (%) n = 2,541 n = 1,529
Known etiology n = 1,507 860 (33.8) 646 (42.2) <0.001
Gram-positive n = 866 466 (18.3) 400 (26.2) <0.001
S. pneumoniae n = 859 (21.1) 463 (18.2) 396 (25.9) <0.001
MRSA n = 7 (0.2) 3 (0.1) 4 (0.3) 0.284
Gram-negative n = 207 123 (4.8) 84 (5.5) 0.358
L. pneumophila n = 104 (2.6) 60 (2.4) 44 (2.9) 0.312
H. inﬂuenza n = 43 (1.1) 25 (1.0) 18 (1.2) 0.559
P. aeruginosa n = 45 (1.1) 30 (1.2) 15 (1.0) 0.555
E. coli n = 15 (0.4) 8 (0.3) 7 (0.5) 0.466
Atypical pathogens n = 144 102 (4.0) 42 (2.7) 0.034
C. pneumoniae n = 44 (1.1) 26 (1) 18 (1.2) 0.645
C. burnetii n = 50 (1.2) 37 (1.5) 13 (0.9) 0.089
M. pneumoniae n = 50 (1.2) 39 (1.5) 11 (0.7) 0.022
Viruses n = 18 11 (0.4) 7 (0.5) 0.908
Mixed etiologyb n = 121 63 (2.5) 58 (3.8) 0.017
Bacteremia n = 284 137 (9.0) 147 (14.5) <0.001
Data are presented as number (percentage) unless otherwise indicated.
a p value: the χ2 test was performed for categorical data.
b Mixed etiology is deﬁned as pneumonia due to more than one pathogen (virus or bacteria).
doi:10.1371/journal.pone.0145929.t003
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community-onset severe-sepsis, whereas prior antibiotic treatment was a protective factor; 3) S
pneumoniae and mixed etiology are the main causal microorganisms of severe sepsis.
Severe-sepsis CAP is not well characterized in terms of the most susceptible population
even though it can appear in over one third of the patients. We have identified the aforemen-
tioned characteristics, two of them related to comorbid conditions. However, diabetes was
more frequent in those without severe sepsis, probably reflecting more lenient hospitalization
criteria in diabetic patients.
At hospital admission, patients with severe-sepsis CAP had higher PSI and CURB65 scores,
although more than half of these patients had a CURB65 score2, pointing out to the limita-
tions of scales for severity assessment. Patients who had initiated outpatient antibiotic treat-
ment presented a lower frequency of severe-sepsis CAP at hospital arrival. Prior studies have
reported the protective effect on mortality when antibiotic therapy was rapidly initiated
between 4 and 6 hours after arrival at the hospital. [7,13] Prompt antibiotic administration
may rapidly reduce the bacterial load, down-regulating the initial inflammatory cascade and
thus decreasing the risk of sepsis. [14,15] On initial severity assessment of CAP, severe sepsis
criteria should be taken into account for decision-making process including allocation, moni-
toring and management. [6]
The multivariable statistical analyses results confirm that alcohol abuse and two comorbid
conditions (COPD and renal disease) were independent host risk factors for developing severe-
sepsis CAP in the community. The impact of alcohol on developing severe CAP has been
linked to an abnormal immune response. [15–18] Curiously, despite the increased risk for
severe CAP in COPD patients, mortality is not higher probably due to the use of previous anti-
biotics and corticosteroids that reduce inflammatory response. [19,20] Our results suggest that
patients with alcohol abuse, COPD and renal diseases should be specifically targeted for pre-
ventive strategies when in contact with health systems, that is, at discharge or during scheduled
outpatient visits. Moreover, if treated as outpatients for CAP, they should be closely monitored
and receive instructions to rapidly recognize the signs of sepsis.
Bacteremia and etiological microorganisms are more frequently identified when CAP pres-
ents with severe sepsis, most likely due to a higher burden of pathogens in most severe epi-
sodes.[2,21] S pneumoniae was the most frequently isolated microorganism in severe CAP
Table 4. Multivariable analysis results of severe sepsis related to host factors (first model) andmicroorganisms (secondmodel).
Severe Sepsis n = 1,529
ORa 95% CIb p
First model: Host factors
Demographic data and habits Age (65 years) 1.34 1.15–1.55 <0.001
Alcohol abuse 1.31 1.07–1.61 0.010
Comorbid condition Diabetes Mellitus 0.74 0.63–0.88 <0.001
Renal disease 1.57 1.22–2.03 0.001
COPD 1.75 1.50–2.04 <0.001
Prior antibiotic treatment 0.62 0.52–0.73 <0.001
Second model: Microorganisms
Etiology S. pneumoniae 1.59 1.31–1.95 <0.001
L. pneumophila 1.81 1.14–2.86 0.012
Mixed etiology 1.65 1.10–2.49 0.017
Bacteremia 1.37 1.05–1.79 0.021
a OR: Odds ratio.
b CI: Conﬁdence interval.
doi:10.1371/journal.pone.0145929.t004
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[1,22,23] and specifically, some serotypes have been independently associated with septic
shock.[24] Mixed etiology was the second most common etiology in severe sepsis CAP, under-
pinning the impact of associated microorganisms on severity. Patients presenting with severe
sepsis should benefit of optimizing microbiological tests to rule out bacteremia and mixed eti-
ology, immediately before initiating a combination antibiotic therapy.
This study has some limitations. We have excluded the nursing-home population and
patients with CAP considered a terminal event in order to avoid a different population with
different characteristics, more frequent nosocomial infections and/or multidrug resistant
microorganisms and limited therapeutic efforts; therefore our findings are not applicable to
that subset of population. Second, microbiological diagnosis with regard to viruses was incom-
plete in a considerable subset of patients, the percentage of blood cultures was suboptimal
(62.7%), and determination of S pneumoniae serotypes was not performed. The indications of
microbiological tests in our study relied on the attending physicians. Third, the information
regarding septic shock was not recorded. Nevertheless, our strengths are the large sample size
and the prospective study design.
Conclusions
Elderly patients, alcohol abusers and some comorbidities, such as COPD and renal are predis-
posing conditions for progressing to severe sepsis CAP in the community, mainly due to S
pneumoniae and mixed etiologies. Those findings may have clinical implications for patients
and physicians in primary care and emergency rooms. Preventive CAP strategies such as vacci-
nation–influenza and S pneumoniae—and health measures recommended in guidelines should
be reinforced in the most susceptible patients. Recognition of severe-sepsis CAP signals should
be encouraged for patients and for physicians in primary care and/or emergency rooms. Initial
severity CAP assessment could be improved by evaluation of severe sepsis criteria at diagnosis
in order to optimize microbiological and analytical tests, to provide closer monitoring and a
rapid antibiotic treatment. Efforts should be directed to encouraging actions to reduce the bur-
den of severe-sepsis CAP episodes and facilitate its prompt recognition.
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